Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective Study-Reference-Cited by-同舟云学术

Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective Study

Published:2022-12 Issue: Volume:137 Page:41-48
ISSN:0887-8994
Container-title:Pediatric Neurology
language:en
Short-container-title:Pediatric Neurology

Author:

Nguyen Ai Tien,Cotteret Camille,Durrleman Chloé,Barnerias Christine,Hully Marie,Gitiaux Cyril,Mesples Bettina,Bustamante Jacinta,Chhun Stéphanie,Fayard Claire,Cisternino Salvatore,Treluyer Jean-Marc,Desguerre Isabelle,Aubart Mélodie

Publisher

Elsevier BV

Subject

Neurology (clinical),Developmental Neuroscience,Neurology,Pediatrics, Perinatology and Child Health

Reference29 articles.

1. Rituximab pharmacokinetics in patients with rheumatoid arthritis: B-cell levels do not correlate with clinical response;Breedveld;J Clin Pharmacol,2007

2. Rituximab in neurological disease: principles, evidence and practice;Whittam;Pract Neurol,2019

3. Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance;Smith;Oncogene,2003

4. Indications for rituximab use in an integrated health care delivery system;Delate;J Manag Care Spec Pharm,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The experience of anti-b-cell therapy with rituximab in children with chronic inflammatory demyelinating polyradiculoneuropathy with a description of the clinical case;Russian Journal for Personalized Medicine;2024-09-13

2. Safety of Obinutuzumab in Children With Autoimmune Encephalitis and Early B-Cell Repopulation on Rituximab;Pediatric Neurology;2024-07

3. Successful use of tacrolimus for treatment‐refractory neuroblastoma‐associated opsoclonus‐myoclonus‐ataxia syndrome: A case series;Pediatric Blood & Cancer;2024-02-06

4. Rituximab;Reactions Weekly;2023-06-10